You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
| Title |
Trastuzumab, an appropriate first-line single-agent therapy for HER2-overexpressing metastatic breast cancer
|
|---|---|
| Published in |
Breast Cancer Research, April 2003
|
| DOI | 10.1186/bcr574 |
| Pubmed ID | |
| Authors |
Carlos L Arteaga |
Mendeley readers
The data shown below were compiled from readership statistics for 54 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 2% |
| Russia | 1 | 2% |
| Unknown | 52 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 12 | 22% |
| Student > Bachelor | 8 | 15% |
| Student > Ph. D. Student | 8 | 15% |
| Researcher | 6 | 11% |
| Student > Doctoral Student | 4 | 7% |
| Other | 8 | 15% |
| Unknown | 8 | 15% |
| Readers by discipline | Count | As % |
|---|---|---|
| Agricultural and Biological Sciences | 15 | 28% |
| Medicine and Dentistry | 12 | 22% |
| Biochemistry, Genetics and Molecular Biology | 7 | 13% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 6% |
| Immunology and Microbiology | 3 | 6% |
| Other | 5 | 9% |
| Unknown | 9 | 17% |